Chemoperfusion and embolization in the treatment of liver metastases;Chemoperfusion und -embolisation von Lebermetastasen

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 183, Issue 1, 2011, Pages 12-23

  Vogl, Thomas J ^a   MacK, M G ^a   Eichler, K ^a   Zangos, S ^a   Naguib, N N ^a   Gruber Rouh, T ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

liver metastases; MRI; regional chemotherapies

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC LOADED MICROSPHERE; MICROSPHERE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; LASER THERMOTHERAPY; LIVER METASTASIS; MICROWAVE THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SELECTIVE INTERNAL RADIATION THERAPY;

BREAST NEOPLASMS; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; ENDOCRINE GLAND NEOPLASMS; FEMALE; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MIDDLE AGED; RADIOTHERAPY;

EID: 78650679915     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0029-1245880     Document Type: Article

References (125)

1. Pickren J W., Tsukada Y, Lane W W. Liver metastases. Analysis of autopsy data. In Weiss L Gilbert H A. (Eds) Liver metastases. Boston GK Hall Medical 1982 2-18
2. Bläker H, Hofmann W J., Theuer D et al. Pathologische Befunde bei Lebermetastasen. Der Radiologe 2001 41 1-7
3. Edmunson H A., Craig J R. Neoplasms of the liver. Schiff L (Ed) Diseases of the liver. Philadelphia Lippincott 1987 1109-1158
4. Nizze H, Hebecker R, Strohpahl G et al. Primäre und sekundäre maligne Lebertumore in Autopsie, Biopsie und Zytologie: Häufigkeit und differentialdiagnostische Probleme. Verh Dtsch Ges Pathol 1995 79 137-143
5. Neumann U P., Seehofer D, Neuhaus P. Chirurgische Therapie von Lebermetastasen beim kolorektalen Karzinom. Dtsch Arztebl Int 2010 107 335-342
6. Jonker D J., Maroun J A., Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer 2000 82 1789-1794
7. Pool A E., Méndez Romero A van der, Wunderink W et al. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 2010 97 377-382
8. Seidensticker M, Wust P, Rühl R et al. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol 2010 5 24
9. Ricke J, Wieners G, Pech M et al. CT-gesteuerte Brachytherapie versus Laserablation (LITT): Ergebnisse einer match-pair Analyse an identischen Patienten. Fortschr Röntgenstr 2006 S1 178
10. Ricke J, Mohnike K, Pech M et al. Local Response and Impact on Survival After Local Ablation of Liver Metastases from Colorectal Carcinoma by Computed Tomography-Guided High-Dose-Rate Brachytherapy. Int J Radiat Oncol Biol Phys 2010 78 479-485
11. Brown D B., Geschwind J FH, Soulen M C. et al. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. JVasc Interv Radiol 2006 17 217-223
12. Vogl T J., Trapp M, Schroeder H et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success - results from a liver transplantation center. Radiology 2000 214 349-357
13. Stuart K. Chemoembolization in the management of liver tumors. Oncologist 2003 8 425-437
14. Llovet J M., Real M I., Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002 359 1734-1739
15. Takayasu K, Arii S, Ikai I et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006 131 461-469
16. Vogl T J., Zangos S, Eichler K et al. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 2007 17 1025-1034
17. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954 30 969-977
18. Vogl T J., Mack M G., Balzer J O. et al. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 2003 229 457-464
19. Chen H S., Gross J F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980 64 31-40
20. Wallace S, Carrasco C H., Charnsangavej C et al. Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc Intervent Radiol 1990 13 153-160 (Pubitemid 20269114)
21. Wang L Q., Persson B G., Bergqvist l et al. Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein. Cancer 1994 74 2454-2459
22. Tancredi T, McCuskey P A., Kan Z et al. Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents. Radiology 1999 211 177-181
23. Seldinger S I. Catheter replacement of needle in percutaneous arteriography: a new technique. Acta Radiol 1953 39 368-372
24. Sullivan R D., Watkins Jr E, Zurek W Z. Cancer chemotherapy by prolonged ambulatory arterial infusion. Proc Natl Cancer Conf 1964 5 543-559
25. Collins J M. Pharmacologic rationale for regional drug delivery. JClin Oncol 1984 2 498-504
26. Link K H., Prei J. Prinzipien der lokoregionalen Therapie. In Schmoll H J. Höffken K Possinger K (eds) Kompendium internistische Onkologie. Berlin Heidelberg Springer 2006 873-881
27. Sumie S, Yamashita F, Ando E et al. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. Am J Roentgenol 2003 181 1327-1334
28. Brown D B., Cardella J F., Sacks D et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. JVasc Inter Radiol 2006 17 225-232
29. Vogl T J., Zangos S, Balzer J O. et al. Transarterielle Chemoembolisation (TACE) deshepatozellulären Karzinoms: Technik, Indikationsstellung und Ergebnisse. Fortschr Röntgenstr 2007 179 1113-1126
30. Lubienski A, Simon M, Lubienski K et al. Update Chemoperfusion und -embolisation. Radiologe 2007 47 1097-1106, 1108
31. Jaeger H J., Mehring U M., Castaneda F et al. Seguential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 1996 19 388-396
32. Fan J, Thang Z Y., Yu Y Q. et al. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 1998 15 674-678
33. López-Bentez R, Radeleff B A., Barragán-Campos H M. et al. Acute pancreatitis after embolization of liver tumors: frequency and associated risk factors. Pancreatology 2007 7 53-62
34. Helmberger T. Interventionelle Verfahren bei Lebermetastasen. Chirurg 2010 81 542-550
35. Martin R C., Robbins K, Tomalty D et al. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 2009 7 80
36. Baere T de, Deschamps F, Teriitheau C et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. JVasc Interv Radiol 2008 19 855-861
37. Eyol E, Boleij A, Taylor R R. et al. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin Exp Metastasis 2008 25 273-282
38. Tang Y, Czuczman P R., Chung S T. et al. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases. JControl Release 2008 127 70-78
39. Tang Y, Taylor R R., Gonzalez M V. et al. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. JControl Release 2006 116 e55-e56
40. Grundmann R T., Hermanek P, Merkel S et al. Arbeitsgruppe Workflow Diagnostik und Therapie von Lebermetastasen kolorektaler Karzinome. [Diagnosis and treatment of colorectal liver metastases - workflow]. Zentralbl Chir 2008 133 267-284
41. Vogl T J., Zangos S, Balzer J O. et al. Transarterielle Chemoembolisation von Lebermetastasen: Indikationsstellung, Technik, Ergebnisse. Fortschr Röngenstr 2002 174 675-683
42. Kennedy A S., Coldwell D, Nutting C et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006 65 412-425
43. Vogl T J., Straub R, Eichler K et al. Moderne Alternativen zur Metastasenresektion - MR-gesteuerte Laser-induzierte Thermotherapie (LITT) und andere local ablative Verfahren. Ther Umsch 2001 58 718-725
44. Solbiati L, Goldberg S N., Ierace T et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997 205 367-373
45. Kemeny N, Niedzwiecki D, Shurgot B et al. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 1989 63 742-747
46. Wagner J S., Adson M A., Van Heerden J A. et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984 199 502-508
47. Bavisotto L M., Patel N H., Althaus S J. et al. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase 2 trial of the Puget Sound Oncology Concortium (PSOC 1104). Clin Cancer Res 1999 5 95-109
48. Germer C T., Buhr H J., Isbert C. Nichtoperative Ablation. Möglichkeiten und Grenzen der Ablationsverfahren zur Behandlung von Lebermetastasen unter kurativer Intention. Chirurg 2005 76 552-554, 556 - 563
49. Kennedy A, Nag S, Salem R et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007 68 13-23
50. Poggi G, Quaretti P, Minoia C et al. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Anticancer Res 2008 28 3835-3842
51. Mulcahy M F., Lewandowski R J., Ibrahim S M. et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009 115 1849-1858
52. Hong K, McBride J D., Georgiades C S. et al. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. JVasc Interv Radiol 2009 20 360-367
53. Kemeny N, Eid A, Stockman J et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. JSurg Oncol 2005 91 97-101 (Pubitemid 41077048)
54. Kemeny N E., Niedzwiecki D, Hollis D R. et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). JClin Oncol 2006 24 1395-1403
55. Tse A N., Wu N, Patel D et al. A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies. Cancer Chemother Pharmacol 2009 64 935-944
56. Hildebrandt B, Pech M, Nicolaou A et al. Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach. BMC Cancer 2007 7 69
57. Lang E K., Brown Jr C L. Colorectal metastases to the liver: selective chemoembolization. Radiology 1993 189 417-422
58. Vogl T J., Gruber T, Balzer J O. et al. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 2009 250 281-289
59. Damjanovic D, Thompson P, Findlay M PN. Evidence-based update of chemotherapy options for metastatic colorectal cancer. ANZ J Surg 2004 74 781-787
60. Hurwitz H, Kabbinavar F. Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer. Oncology 2005 69 17-24
61. Lawes D, Taylor I. Chemotherapy for colorectal cancer - an overview of current management for surgeons. Eur J Surg Oncol 2005 31 932-941
62. Vogl T J., Müller P K., Mack M G. et al. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 1999 9 675-684
63. Gilliams A, Tarantino L, Stefano G de et al. Survival after percutaneous, image-guided. Thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000 43 656-661
64. Shankar A, Lees W R., Gilliams A R. et al. Treatment of reccurent colorectal liver metastases by interstitial laser photocoagulation. Br J Surg 2000 87 298-300
65. Meade V M., Burton M A., Gray B N. et al. Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncol 1987 23 37-41
66. Burton M A., Gray B N., Kelleher D K. et al. Selective internal radiation therapy: validation of intraoperative dosimetry. Radiology 1990 175 253-255
67. Burton M A., Gray B N., Klemp P F. et al. Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol 1989 25 1487-1491
68. Gray B N., Burton M A., Kelleher D K. et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. JSurg Oncol 1989 42 192-196
69. Gray B N., Burton M A., Kelleher D et al. Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys 1990 18 619-623
70. Stubbs R, Wickremesekera S. Selective internal radiation therapy (SIRT): a new modality for treating patients with colorectal liver metastases. HPB 2004 6 133-139
71. Stubbs R S., O'Brien I, Correia M M. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 2006 76 696-703
72. Fiorentini G, Aliberti C, Benea G et al. TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects. Hepatogastroenterology 2008 55 2077-2082
73. Hoe A L., Royle G T., Taylor I. Breast liver metastases - incidence, diagnosis and outcome. JR Soc Med 1991 84 714-716
74. Mack M G., Straub R, Eichler K et al. Breast cancer metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004 233 400-409 (Pubitemid 39423798)
75. Kasper H U., Drebber U, Dries V et al. Lebermetastasen: Inzidenz und histogenetischeEinordnung. Z Gastroenterol 2005 43 1149-1157
76. Bathe O F., Kaklamanos I G., Moffat F L. et al. Metastatectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer. Surg Oncol 1999 8 35-42
77. Vogl T J., Mack M G., Straub R et al. Interventionelle laserinduzierte Thermotherapie von Lebermetastasen des Mammakarzinoms. Methodik und klinische Ergebnisse. Gynäkologe 1999 32 666-674
78. Livraghi T, Goldberg S N., Solbiati L et al. Percutaneous radiofrequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001 220 145-149
79. Ikeda T, Adachi I, Takashima S et al. A phase I/II study of continous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) Study 9113. Jpn J Clin Oncol 1999 29 23-27
80. Li X P., Meng Z Q., Guo W J. et al. Treatment for liver metastases from breast cancer: results and prognostic factors. World J Gastroenterol 2005 11 3782-3787
81. Pentheroudakis G, Fountzilas G, Bafaloukos D et al. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 2006 97 237-244
82. Schneebaum S, Walker M J., Young D et al. The regional treatment of liver metastases from breast cancer. JSurg Oncol 1994 55 26-31
83. Giroux M F., Baum R A., Soulen M C. Chemoembolization of liver metastases from breast carcinoma. JVasc Interv Radiol 2004 15 289-291
84. Eichbaum M H., Kaltwasser M, Bruckner T et al. Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 2006 96 53-62
85. Lee M T., Kim J J., Dinniwell R et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. JClin Oncol 2009 27 1585-1591. Epub 2009 Mar 2
86. Milano M T., Zhang H, Metcalfe S K. et al. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009 115 601-608
87. Coldwell D M., Kennedy A S., Nutting C W. Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 2007 69 800-804
88. Jakobs T F., Hoffmann R T., Fischer T et al. Radioembolization in patients with hepatic metastases from breast cancer. JVasc Interv Radiol 2008 19 683-690
89. Bangash A K., Atassi B, Kaklamani V et al. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. JVasc Interv Radiol 2007 18 621-628
90. Benevento A, Boni L, Frediani L et al. Result of liver resection as treatment for metastases from noncolorectal cancer. JSurg Oncol 2000 74 24-29
91. Lehnert T, Knaebel H P. Diagnostik und Therapie von Lebermetastasen neuroendokriner Tumoren. Der Chirurg 1997 68 122-131
92. Frilling A, Sotiropoulos G C., Li J et al. Multimodal management of neuroendocrine liver metastases. HPB 2010 12 361-379
93. Kress O, Wagner H J., Wied M et al. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - a retrospective single-center analysis. Digestion 2003 68 94-101
94. Oberg K. Chemotherapy and biotherapy in neuroendocrine tumours. Curr Opin Oncol 1993 5 110-120
95. Kvols L K., Moertel C G., O'Connell M J. et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986 315 663-666
96. Christante D, Pommier S, Givi B et al. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery 2008 144 885-893
97. Ruutiainen A T., Soulen M C., Tuite C M. et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. JVasc Interv Radiol 2007 18 847-855
98. Marelli L, Stigliano R et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007 30 6-25
99. Camma C, Schepis F et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002 224 47-54
100. Llovet J M., Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003 37 429-442
101. Touzios J G., Kiely J M., Pitt S C. et al. Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 2005 241 776-783; discussion 783 - 785
102. Hajarizadeh H, Ivancev K, Mueller C R. et al. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg 1992 163 479-483
103. Therasse E, Breittmayer F, Roche A et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993 189 541-547
104. Loewe C, Schindl M, Cejna M et al. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgen 2003 180 1379-1384
105. Kennedy A S., Dezarn W A., McNeillie P et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008 31 271-279
106. Del Freo A, Fiorentini G, Sanguinetti F et al. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer. In Vivo 2006 20 743-746
107. Sanz-Altamira P M., Spence L D., Huberman M S. et al. Selective chemoembolization in the treatment of hepatic metastases in refractory colorectal carcinoma: a phase 2 trial. Dis Colon Rectum 1997 40 770-775
108. Telez C, Benson A B., Lyster M T. et al. Phase 2 trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998 82 1250-1259
109. Leichman C G., Jacobson J R., Modiano M et al. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial. Cancer 1999 86 775-781
110. Wasser K, Giebel F, Fischbach R et al. Transarterielle Chemoembolisation von Lebermetastasen kolorektaler Karzinome mit abbaubaren Stärkepartikeln (Spherex). Eigene Beobachtungen und Literaturübersicht. Radiologe 2005 45 633-643
111. Sharma R A., Van Hazel G A., Morgan B et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. JClin Oncol 2007 25 1099-1106
112. Jakobs T F., Hoffmann R T., Poepperl G et al. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 2007 17 1320-1330
113. Vogl T J., Straub R, Eichler K et al. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004 230 450-458 (Pubitemid 38133806)
114. Gillams A R., Lees W R. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009 19 1206-1213
115. Machi J, Oishi A J., Sumida K et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 2006 12 318-326
116. Vogl T J., Zangos S, Eichler K et al. Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases. Eur Radiol 2008 18 468-476
117. Vogl T J., Naguib N N., Nour-Eldin N E. et al. Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. Eur Radiol 2010 20 173-180
118. Meloni M F., Andreano A, Laeseke P F. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation - intermediate and long-term survival rates. Radiology 2009 253 861-869
119. Ho A S., Picus J, Darcy M D. et al. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. Am J Roentgenol 2007 188 1201-1207
120. Gupta S, Johnson M M., Murthy R et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005 104 1590-1602
121. Vogl T J., Gruber T, Naguib N N. et al. Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. Am J Roentgenol 2009 193 941-947
122. Rhee T K., Lewandowski R J., Liu D M. et al. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 2008 247 1029-1035
123. King J, Quinn R, Glenn D M. et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008 113 921-929
124. Kalinowski M, Dressler M, König A et al. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study. Digestion 2009 79 137-142
125. Gillams A, Cassoni A, Conway G et al. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 2005 30 435-441